Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
Ibuprofen
Alter Pharma
M01AE; M01AE01
Ibuprofen
400 milligram(s)
Film-coated tablet
Propionic acid derivatives; ibuprofen
Not marketed
2015-07-24
PACKAGE LEAFLET: INFORMATION FOR THE USER MIOFEN 400 MG FILM-COATED TABLETS ibuprofen [For medicines available only on prescription: READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions`, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours - If you get any side effects, talk to your doctor or pharmacist. It includes any possible side effects not listed in this leaflet. See section 4]. For medicines available without a prescription: READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - For adults: You must talk to a doctor if you do not feel better or if you feel worse after 3 days with a fever or migraine and 4 days with pain. - For children and adolescents: a doctor should be consulted if in children and in adolescents this medicinal product is required for more than 3 days or if symptoms worsen. WHAT IS IN THIS LEAFLET 1. What Miofen is and what it is used for 2. What you need to know before you take Miofen 3. How to take Miofen 4. Possible side effects 5. How to store Miofen 6. Contents of the pack and other information 1. WHAT MIOFEN IS AND WHAT IT IS USED FOR Miofen belongs to a group of medicines called NSAIDs (non-steroidal anti-inflammatory drugs), reduces fever, relieves pain and has an anti-inflammatory effect For medicines available without a prescription: Miofen is used for short t Lue koko asiakirja
Health Products Regulatory Authority 13 February 2024 CRN00F277 Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Miofen 400mg Film-coated Tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 400mg ibuprofen Excipients: lactose monohydrate 6.19 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White coloured, capsule shaped, biconvex, 16.6 x 7.75mm, film coated tablets, plain on both sides 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For short term symptomatic treatment of: - Pain of mild to moderate intensity. - Fever in adults and adolescents. - Dysmenorrhoea with no organic cause. For symptomatic treatment of rheumatoid arthritis, arthrosis 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The treatment should start with the lowest dose anticipated to be effective, which can subsequently be adjusted, depending on the therapeutic response and any undesirable effects. In long-term treatment a low maintenance dose should be the aim. If in adults this product is required for more than 3 days in the case of fever or migraine headache, or for more than 4 days for pain relief, or if symptoms worsen the patient is advised to consult a doctor. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). _Adults and adolescents over 12 years (> 40 kg):_ _Rheumatic diseases_ One 400 mg tablet three times daily. An interval of at least 4-6 hours should be allowed between doses. For more rapid relief of the morning stiffness, the first dose may be given on a fasting stomach. The dose should be reduced in the event of renal insufficiency. The recommended dosage of Miofen is 1200-1800 mg daily in divided doses. Some patients can be maintained on 600-1200 mg daily. In adolescent the recommended dose is 20 mg/kg to a maximum of 40 mg/kg body weight daily in 3 to 4 doses. The maximum dose in a 24-hour period is 2,400 mg. _ _ _Dysmenorrhoea_ On Lue koko asiakirja